Skip to main content
Lareb logo Menu icon
  • News updates
  • Publications and overviews
  • Education and patient reporting
  • Teratology Information Service (TIS)
  • About Lareb
  • Research and collaborations
  • Contact
Lareb logo
  • About Lareb
  • Contact
Menu icon
Meld een bijwerking van een:
/media/1auhenje/banner-homepage-2.png
  • Home
  • News updates
  • New causality assessment method for ADRs on drugs and vaccines

New causality assessment method for ADRs on drugs and vaccines

28-11-2018

Several causality methods are developed from a theoretical perspective. In daily practice, not all information requested by the causality method is relevant or available, decreasing their applicability. Lareb developed a new causality documentation tool (CausDoc) where an algorithm, taking into account the information present in the report, combined with expert judgement, determines the causality. CausDoc can be used for reports on drugs and vaccines.

CausDoc provides nine structured questions relevant for causality assessment. If the needed information in order to answer the question is available, the questions will be part of the causality algorithm, if the information is not present, the question will not be a part of the causality algorithm. Subsequently, these questions are answered based on the information present and a the causality is calculated. The causality outcome is based on the sum score of all answers divided by the included questions where: ≤30%: unlikely; 31-70%: possible; 71-90%: probable and >90%: certain. If needed, this outcome can be adjusted up or down by one category based on expert judgement, provided with a reason.

The first experiences with this tool are promising. CausDoc shows higher sensitivity and specificity compared to the Naranjo algorithm and the WHO adverse events following immunization (AEFI) criteria.

Reference: Oosterhuis I, Zweers P, Rümke H, Muller‐Hansma A, van Puijenbroek E. A tailor‐made approach for causality assessment for ADR reports on drugs and vaccines. Pharmacoepidemiol Drug Saf. 2018;1–7.

Pharmacovigilance Centre Lareb
  • About Lareb
  • Research and collaborations
  • Contact
Search
  • News updates
  • Publications and overviews
More about
  • Education and patient reporting
  • Teratology Information Service (TIS)
logo
© Lareb. All Rights Reserved. 2025
Dutch | Cookies | Privacy | Disclaimer
Pharmacovigilance Centre Lareb
  • About Lareb
  • Research and collaborations
  • Contact
Search
  • News updates
  • Publications and overviews
More about
  • Education and patient reporting
  • Teratology Information Service (TIS)
logo
© Lareb. All Rights Reserved. 2025
Dutch | Cookies | Privacy Disclaimer

Dat spijt ons. Kun je ons vertellen wat er niet werkte voor jou?

Toelichting